Oric Pharmaceuticals Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | |
| – | +0.3% | +13.8% | -5.6% | -7.5% | +7.7% | +6.8% | +7.3% | +10.2% | |
| – | +216,029.0% | +133.3% | +382.4% | +143.5% | +12.5% | +5.3% | +32.8% | +23.9% | |
| – | +92.8% | +127.7% | +2,206.7% | -49.4% | +12.8% | – | – | – | |
| – | -844.2% | – | +67.6% | +99.2% | -110.9% | – | -59.8% | -377.4% | |
| – | +8.0% | +46.3% | -13.2% | +40.8% | +121.3% | -59.1% | +39.9% | -40.1% | |
| – | +74.0% | +51.2% | +28,019.7% | – | -169.0% | -60.3% | – | -768.7% | |
| – | – | +86.6% | +283.2% | -81.2% | -98.9% | – | – | – | |
| – | +14,518.5% | +86.3% | +253.7% | -80.4% | -48.7% | +239.6% | +47.7% | +95.7% | |
| – | – | +176.6% | -123.0% | – | -207.5% | – | – | -138.1% | |
| – | – | – | – | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.